CoChat
Sign Up
Cited by 178Protease and Inhibitor MechanismsMast cells and histamineBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B.

Open access
LEES, Martyn, TAYLOR, David J., WOOLLEY, David E.·1994·European Journal of Biochemistry
DOI 10.1111/j.1432-1033.1994.tb18980.x
Open this paper in CoChat — free accountOpen PDF

Abstract

Mast cell activation in vivo is often associated with areas of oedema and connective-tissue degradation. Tryptase and chymase are the major serine proteinases released by mast cells, but they appear to have little activity on most components of the extracellular matrix. The matrix metalloproteinases (MMP) are purported to degrade almost all connective tissue elements and are secreted by cells in the form of inactive precursors. Since the mechanisms of MMP activation in vivo are poorly understood we have examined the potential of mast cell proteinases to activate the precursor forms of human collagenase (MMP-1), stromelysin (MMP-3), gelatinase A (MMP-2) and gelatinase B (MMP-9). Mast cell proteinases prepared from purified dog mastocytoma cells were shown to process and activate purified precursor forms of both MMP-1 and MMP-3. Using antipain and chymostatin, inhibitors for tryptase and chymase, respectively, it was demonstrated that both pMMP-1 and pMMP-3 were effectively processed and activated by the chymase component. By contrast, tryptase activated only pMMP-3. The mast cell proteinases were unable to process or activate purified precursor forms of MMP-2 and MMP-9. However, MMP-3 previously activated by mast cell proteinases was shown to activate pMMP-9, but not pMMP-2. Since we have no evidence that mast cells express these four metalloenzymes, the release of mast cell serine proteinases following activation/degranulation could contribute to local metalloproteinase activation and subsequent matrix degradation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1432-1033.1994.tb18980.x

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 8

  1. Nagase H., 1992, Matrix Suppl. no, 1, 421
  2. Nagase H. Y., 1991, Biomed. Biochim. Acta, 50, 749
  3. Faraj V. A., 1984, J. Nucl. Med, 25, 56
  4. Walsh K. A., 1970, Methods in Enzymology, 41
  5. Grant G. A., 1992, Matrix metalloproteinases and inhibitors, 217
  6. Murphy G., 1992, Matrix metalloproteinases and inhibitors, 224
  7. Nagase H., 1992, Matrix metalloproteinases and inhibitors, 237
  8. Norrby K., 1993, Advances Biosci, 89, 71

Cited by

Sorted by citations

Related

See all

Metadata

Authors
LEES, M., TAYLOR, D. J., & WOOLLEY, D. E.
Affiliations
University of Manchester (GB)
Corresponding author
WOOLLEY, David E.
ORCID
TAYLOR, David J.
Venue
European Journal of Biochemistry
Publisher
Wiley
Published
1994-07
Volume
223
Issue
1
Pages
171-177
ISSN
  • 0014-2956 (ISSN-L)
  • 1432-1033
DOI
10.1111/j.1432-1033.1994.tb18980.x
OpenAlex
W1995941626
Cited by
178
References
38
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 6 · 2012: 3
FWCI
5.13
Type
journal article
Language
en
Open access
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor, 3898 d)
Locations
  • European Journal of Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
mast cells, matrix metalloproteinase activation, collagenase, stromelysin, MMP-2, MMP-9, tryptase, chymase, serine protease, extracellular matrix degradation, connective tissue, mastocytoma cells, degranulation, edema
MeSH terms
Amino Acid Sequence, Animals, Dogs, Enzyme Activation, Enzyme Precursors, Extracellular Matrix, Humans, Mast Cells, Metalloendopeptidases, Molecular Sequence Data, Endopeptidases, Collagenases, Gelatinases, Matrix Metalloproteinase 3, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review